Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening

被引:3
作者
Liebermann, Erica [1 ,2 ]
Fontenot, Holly B. [3 ]
Lim, Eunjung [4 ]
Matsunaga, Masako [4 ]
Zimet, Gregory [5 ]
Allen, Jennifer D. [6 ]
机构
[1] Univ Rhode Isl, Coll Nursing, RINEC, 350 Eddy St, Providence, RI 02903 USA
[2] Univ Rhode Isl, Coll Nursing, Providence, RI USA
[3] Univ Hawaii Manoa, Nancy Atmospera Walch Sch Nursing, Honolulu, HI USA
[4] Univ Hawaii Manoa, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI USA
[5] Indiana Univ, Sch Med, Indianapolis, IN USA
[6] Tufts Univ, Sch Arts & Sci, Dept Community Hlth, Medford, MA USA
来源
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING | 2023年 / 52卷 / 05期
关键词
HEALTH-CARE PROVIDERS; WOMEN; ACCEPTABILITY; PARTICIPATION; PERSPECTIVES;
D O I
10.1016/j.jogn.2023.05.114
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: To examine associations among women's preferred locations for human papillomavirus (HPV) self-sampling in relation to their demographic, social, and health characteristics and their perceived benefits and concerns regarding this procedure.Design: Cross-sectional, descriptive survey.Setting: Online distribution between March 2022 and April 2022.Participants: People who were assigned female sex at birth and were eligible for cervical cancer screening (N = 367: cis-gender women, n = 364; another gender identity, n = 3).Methods: We used quota sampling to obtain a racially and ethnically diverse sample. We conducted bivariate analyses to examine differences in participants' preferred locations for HPV self-sampling by sociodemographic and health characteristics. We used a multinomial logistic regression model to examine the associations between preferred HPV self-sampling location, characteristics of participants, and perceived benefits and concerns regarding this procedure.Results: In our sample, 43% (n = 158) of participants preferred HPV self-sampling at the office of a health care provider, 50% (n = 182) preferred HPV self-sampling anywhere (office or home), and 7% (n = 27) did not feel comfortable with HPV self-sampling anywhere. Participants 39 to 45 years of age were more likely to prefer HPV self sampling anywhere (office or home) than participants 27 to 32 years of age, OR = 2.47, 95% confidence interval (CI) [1.21, 5.06]. Participants who preferred HPV self-sampling anywhere perceived greater benefit related to limited geographic access to a clinic compared to those who preferred office only, OR = 1.82, 95% CI [1.08, 3.07]. Participants who preferred HPV self-sampling anywhere had less concern related to performing the procedure accurately than those who preferred office only, OR = 0.44, 95% CI [0.31, 0.62].Conclusion: HPV self-sampling is an alternative strategy to increase cervical cancer screening. As providers consider implementation of HPV self-sampling, our findings suggest that office and home-based collection strategies should be considered to increase access to cervical cancer screening.
引用
收藏
页码:364 / 373
页数:10
相关论文
共 37 条
  • [31] Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland
    Virtanen, Anni
    Anttila, Ahti
    Luostarinen, Tapio
    Nieminen, Pekka
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (11) : 2681 - 2687
  • [32] European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
    von Karsa, Lawrence
    Arbyn, Marc
    De Vuyst, Hugo
    Dinner, Joakim
    Dinner, Lena
    Franceschi, Silvia
    Patnick, Julietta
    Ronco, Guglielmo
    Segnan, Nereo
    Suonio, Eero
    Tornberg, Sven
    Anttila, Ahti
    [J]. PAPILLOMAVIRUS RESEARCH, 2015, 1 : 22 - 31
  • [33] Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study
    Wikstrom, I.
    Lindell, M.
    Sanner, K.
    Wilander, E.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (03) : 337 - 339
  • [34] Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment A Randomized Clinical Trial
    Winer, Rachel L.
    Lin, John
    Tiro, Jasmin A.
    Miglioretti, Diana L.
    Beatty, Tara
    Gao, Hongyuan
    Kimbel, Kilian
    Thayer, Chris
    Buist, Diana S. M.
    [J]. JAMA NETWORK OPEN, 2019, 2 (11)
  • [35] Strategies to reach marginalized women for cervical cancer screening: A qualitative study of stakeholder perspectives
    Wood, B.
    Lofters, A.
    Vahabi, M.
    [J]. CURRENT ONCOLOGY, 2018, 25 (01) : E8 - E16
  • [36] World Health Organization, 2021, WHO GUID SCREEN TREA, V2nd
  • [37] Perspectives from Healthcare Providers and Women about Completing Human Papillomavirus (HPV) Self-Testing at Home
    Zimmermann, B. J.
    Katz, M. L.
    Moore, D.
    Paskett, E. D.
    Reiter, P. L.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03) : 560 - 560